Avior Wealth Management LLC lifted its holdings in shares of The Allstate Co. (NYSE:ALL – Free Report) by 4.9% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,329 shares of the insurance provider’s stock after acquiring an additional 62 shares during the quarter. Avior Wealth Management LLC’s holdings in Allstate were worth $252,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. SPC Financial Inc. lifted its position in shares of Allstate by 3.6% in the 3rd quarter. SPC Financial Inc. now owns 1,564 shares of the insurance provider’s stock worth $297,000 after purchasing an additional 54 shares during the period. Lake Street Advisors Group LLC boosted its position in Allstate by 1.8% during the 3rd quarter. Lake Street Advisors Group LLC now owns 3,129 shares of the insurance provider’s stock valued at $596,000 after acquiring an additional 54 shares in the last quarter. Abacus Planning Group Inc. grew its holdings in shares of Allstate by 2.4% during the 3rd quarter. Abacus Planning Group Inc. now owns 2,416 shares of the insurance provider’s stock worth $458,000 after acquiring an additional 56 shares during the period. Chicago Partners Investment Group LLC raised its position in shares of Allstate by 1.3% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 4,630 shares of the insurance provider’s stock worth $893,000 after acquiring an additional 59 shares in the last quarter. Finally, Carmichael Hill & Associates Inc. lifted its stake in shares of Allstate by 15.0% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 460 shares of the insurance provider’s stock valued at $87,000 after purchasing an additional 60 shares during the period. Hedge funds and other institutional investors own 76.47% of the company’s stock.
Insider Activity
In other Allstate news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the transaction, the insider now owns 27,364 shares in the company, valued at $5,236,922.32. The trade was a 57.06 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 1.80% of the company’s stock.
Allstate Stock Up 0.2 %
Allstate (NYSE:ALL – Get Free Report) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.20 by $1.71. The company had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The firm’s quarterly revenue was up 14.7% compared to the same quarter last year. During the same period in the previous year, the business posted $0.81 earnings per share. As a group, sell-side analysts predict that The Allstate Co. will post 16.01 EPS for the current year.
Allstate Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th will be issued a $0.92 dividend. The ex-dividend date is Friday, November 29th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.81%. Allstate’s dividend payout ratio (DPR) is presently 23.83%.
Wall Street Analysts Forecast Growth
Several equities analysts have commented on ALL shares. StockNews.com lowered Allstate from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 21st. Piper Sandler lifted their price target on shares of Allstate from $188.00 to $196.00 and gave the company an “overweight” rating in a research report on Friday, August 16th. UBS Group upped their price objective on shares of Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, November 4th. TD Cowen lifted their target price on shares of Allstate from $193.00 to $224.00 and gave the company a “buy” rating in a report on Tuesday, September 3rd. Finally, Keefe, Bruyette & Woods upped their price target on Allstate from $222.00 to $225.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $214.19.
Read Our Latest Stock Analysis on Allstate
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
- Five stocks we like better than Allstate
- What is a Death Cross in Stocks?
- Tesla Investors Continue to Profit From the Trump Trade
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- Consumer Staples Stocks, Explained
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.